June 22, 2020 / 12:50 PM / 20 days ago

BRIEF-Rubius Therapeutics Inc - Plan To File Investigational New Drug Application By End Of 2020."

Rubius Therapeutics Inc:

* RUBIUS THERAPEUTICS HIGHLIGHTS PRECLINICAL DATA FOR RTX-321, A RED CELL THERAPEUTIC ONCOLOGY PRODUCT CANDIDATE FOR HPV-POSITIVE CANCERS

* RUBIUS THERAPEUTICS INC - PLAN TO FILE INVESTIGATIONAL NEW DRUG APPLICATION BY END OF 2020.” Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below